131 related articles for article (PubMed ID: 9686570)
41. Differential modulation of G1-S-phase cyclin-dependent kinase 2/cyclin complexes occurs during the acquisition of a polyploid DNA content.
Datta NS; Williams JL; Long MW
Cell Growth Differ; 1998 Aug; 9(8):639-50. PubMed ID: 9716181
[TBL] [Abstract][Full Text] [Related]
42. G1-checkpoint function including a cyclin-dependent kinase 2 regulatory pathway as potential determinant of 7-hydroxystaurosporine (UCN-01)-induced apoptosis and G1-phase accumulation.
Akiyama T; Sugiyama K; Shimizu M; Tamaoki T; Akinaga S
Jpn J Cancer Res; 1999 Dec; 90(12):1364-72. PubMed ID: 10665655
[TBL] [Abstract][Full Text] [Related]
43. Mimosine arrests cells in G1 by enhancing the levels of p27(Kip1).
Wang G; Miskimins R; Miskimins WK
Exp Cell Res; 2000 Jan; 254(1):64-71. PubMed ID: 10623466
[TBL] [Abstract][Full Text] [Related]
44. Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells.
Sánchez-Beato M; Camacho FI; Martínez-Montero JC; Sáez AI; Villuendas R; Sánchez-Verde L; García JF; Piris MA
Blood; 1999 Jul; 94(2):765-72. PubMed ID: 10397744
[TBL] [Abstract][Full Text] [Related]
45. Role of proteasomes in T cell activation and proliferation.
Wang X; Luo H; Chen H; Duguid W; Wu J
J Immunol; 1998 Jan; 160(2):788-801. PubMed ID: 9551914
[TBL] [Abstract][Full Text] [Related]
46. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
[TBL] [Abstract][Full Text] [Related]
47. CTLA-4-Mediated inhibition of early events of T cell proliferation.
Brunner MC; Chambers CA; Chan FK; Hanke J; Winoto A; Allison JP
J Immunol; 1999 May; 162(10):5813-20. PubMed ID: 10229815
[TBL] [Abstract][Full Text] [Related]
48. Cyclin D3-associated kinase activity is regulated by p27kip1 in BALB/c 3T3 cells.
Dong F; Agrawal D; Bagui T; Pledger WJ
Mol Biol Cell; 1998 Aug; 9(8):2081-92. PubMed ID: 9693368
[TBL] [Abstract][Full Text] [Related]
49. Failure of T lymphocytes from elderly humans to enter the cell cycle is associated with low Cdk6 activity and impaired phosphorylation of Rb protein.
Arbogast A; Boutet S; Phelouzat MA; Plastre O; Quadri R; Proust JJ
Cell Immunol; 1999 Oct; 197(1):46-54. PubMed ID: 10555995
[TBL] [Abstract][Full Text] [Related]
50. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
Rao S; Lowe M; Herliczek TW; Keyomarsi K
Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
[TBL] [Abstract][Full Text] [Related]
51. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
Chen WJ; Chang CY; Lin JK
Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
[TBL] [Abstract][Full Text] [Related]
52. BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression.
Parada Y; Banerji L; Glassford J; Lea NC; Collado M; Rivas C; Lewis JL; Gordon MY; Thomas NS; Lam EW
J Biol Chem; 2001 Jun; 276(26):23572-80. PubMed ID: 11323429
[TBL] [Abstract][Full Text] [Related]
53. Involvement of p27(kip1) and cyclin D3 in the regulation of cdk2 activity during skeletal muscle differentiation.
Chu CY; Lim RW
Biochim Biophys Acta; 2000 Jul; 1497(2):175-85. PubMed ID: 10903422
[TBL] [Abstract][Full Text] [Related]
54. Differential modulation of cyclin-dependent kinase inhibitor p27Kip1 by negative signaling via the antigen receptor of B cells and positive signaling via CD40.
Han H; Nomura T; Honjo T; Tsubata T
Eur J Immunol; 1996 Oct; 26(10):2425-32. PubMed ID: 8898956
[TBL] [Abstract][Full Text] [Related]
55. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV
Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653
[TBL] [Abstract][Full Text] [Related]
56. Evidence for a p23 caspase-cleaved form of p27[KIP1] involved in G1 growth arrest.
Loubat A; Rochet N; Turchi L; Rezzonico R; Far DF; Auberger P; Rossi B; Ponzio G
Oncogene; 1999 Jun; 18(22):3324-33. PubMed ID: 10362353
[TBL] [Abstract][Full Text] [Related]
57. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
Greider C; Chattopadhyay A; Parkhurst C; Yang E
Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
[TBL] [Abstract][Full Text] [Related]
58. Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex.
Ellis M; Chew YP; Fallis L; Freddersdorf S; Boshoff C; Weiss RA; Lu X; Mittnacht S
EMBO J; 1999 Feb; 18(3):644-53. PubMed ID: 9927424
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
60. CD28 induces cell cycle progression by IL-2-independent down-regulation of p27kip1 expression in human peripheral T lymphocytes.
Boonen GJ; van Dijk AM; Verdonck LF; van Lier RA; Rijksen G; Medema RH
Eur J Immunol; 1999 Mar; 29(3):789-98. PubMed ID: 10092081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
